Navigation Links
CV Therapeutics Announces Archives of Internal Medicine Publication of Study Showing 20 Percent of Heart Attack Patients in Premier Registry Experienced Angina at One Year
Date:6/23/2008

1 million people in the United States have chronic angina, and 500,000 new cases are diagnosed annually, according to the American Heart Association.

About CV Therapeutics

CV Therapeutics, Inc., headquartered in Palo Alto, California, is a biopharmaceutical company primarily focused on applying molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases.

CV Therapeutics' approved products in the United States include Ranexa(R) (ranolazine extended-release tablets), indicated for the treatment of chronic angina in patients who have not achieved an adequate response with other antianginal drugs, and Lexiscan(TM) (regadenoson) injection for use as a pharmacologic stress agent in radionuclide myocardial perfusion imaging in patients unable to undergo adequate exercise stress.

Except for the historical information contained herein, the matters set forth in this press release, including statements as to research and development and commercialization of products, are forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially, including operating losses and fluctuations in operating results; capital requirements; regulatory review and approval of our products; special protocol assessment agreement; the conduct and timing of clinical trials; commercialization of products; market acceptance of products; product labeling; concentrated customer base; reliance on strategic partnerships and collaborations; uncertainties in drug development; uncertainties regarding intellectual property and other risks detailed from time to time in CV Therapeutics' SEC reports, including its Quarterly Report on Form 10-Q for the quarter ended March 31, 2008. CV Therapeutics disclaims any
'/>"/>

SOURCE CV Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Pilot Therapeutics Announces Relaunch as Gene Smart(TM) Health
2. Cell Therapeutics, Inc. (CTI) to Hold Conference Call to Discuss Agreement With Bayer Schering Pharma for Access to Phase III Zevalin(R) FIT Trial Data
3. PTC Therapeutics Announces Data from Additional Clinical Studies of PTC124 in Cystic Fibrosis Confirming Activity
4. Duska Therapeutics Licenses Portfolio of Heart Failure Drugs From Duke and Johns Hopkins
5. Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability
6. Synvista Therapeutics Reports Results of Three Phase 2 Clinical Trials of SYI-2074 in Diabetic Patients with Cardiovascular Disease
7. Arno Therapeutics, Inc. Completes $18 Million Financing and Reverse Merger with Laurier International, Inc.
8. TorreyPines Therapeutics Initiates Clinical Trial to Evaluate Analgesic Effect of Oral Prodrug of Tezampanel
9. BN ImmunoTherapeutics Starts Clinical Trials With Prostate Cancer Vaccine
10. Amicus Therapeutics Begins Phase 2 Clinical Trial of AT2220 in Pompe Disease
11. Access Pharmaceuticals Presents New Data on the Companys Cobalamin(TM) Technology at an International Polymer Therapeutics Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)...  Alere Inc. (NYSE: ALR ), a ... Juliet Cunningham as Vice President, Investor Relations. In ... driving communications with the investment community. "As ... to increase shareholder value, it is critical that we ... Chief Executive Officer. "We are delighted that Juliet ...
(Date:11/21/2014)... 21, 2014  Tandem Diabetes Care ® , ... device company and manufacturer of the t:slim ® ... Tidepool, a non-profit dedicated to improving diabetes therapy ... that increases diabetes data accessibility. This partnership will ... currently under development, to download and access data ...
(Date:11/21/2014)... SAN MARCOS, Texas , Nov. 21, 2014 /PRNewswire/ ... industrial hemp containing low THC, announces they are now ... is comparable to Charlotte,s Web type strains grown in ... symptoms from other neurological disorders, such as Parkinson,s, MS, ... waiting for US laws to pass, because imported CBD ...
Breaking Medicine Technology:Alere Appoints Juliet Cunningham to Lead Investor Relations 2Tandem Diabetes Care Announces Partnership with Tidepool to Further Expand Access to Diabetes Device Data 2Tandem Diabetes Care Announces Partnership with Tidepool to Further Expand Access to Diabetes Device Data 3New CBD Oil From Industrial Hemp is Comparable to Charlotte's Web, Legal In All 50 States 2New CBD Oil From Industrial Hemp is Comparable to Charlotte's Web, Legal In All 50 States 3
... The U.S. Food and Drug Administration today approved Soliris ... (aHUS), a rare and chronic blood disease that can ... with increased risk of death and stroke. ... HUS accounts for 5 to 10 percent of all ...
... Internal Fixation Systems, Inc. (OTC QB: IFIX), manufacturer ... podiatric implants announced today that the company has been ...  DTC eligibility allows ownership of the company,s shares to ... Depository Trust Company is a member of the U.S. ...
Cached Medicine Technology:FDA Approves Soliris for Rare Pediatric Blood Disorder 2FDA Approves Soliris for Rare Pediatric Blood Disorder 3Internal Fixation Systems, Inc. Announces DTC Eligibility 2
(Date:11/23/2014)... 2014 Asher Milgrom, is a ... Wellness was recently featured on International Business ... and CEO of American Medical Aesthetics & Wellness, also ... a full scholarship to attend an M.D./Ph.D program at ... the University of Chicago, where his field of study ...
(Date:11/23/2014)... OH (PRWEB) November 23, 2014 Syngenta ... LLC on behalf of farmers and agribusinesses that have ... attempts to commercialize Agrisure Viptera and Agrisure Duracade, ... not been approved for sale in China. According to ... China to virtually ban U.S. corn imports. Because China ...
(Date:11/23/2014)... City, Utah (PRWEB) November 23, 2014 ... health insurance reimbursement for small businesses, announced their ... book, The End of Employer-Provided Health Insurance. ... insurance is the greatest financial risk facing most ... facing U.S. employers, small and large, when it ...
(Date:11/22/2014)... Cancer researchers in New York and Minnesota ... tunnels and the growth and spread of mesothelioma. ... the Surviving Mesothelioma website. , Doctors at Memorial ... have just released their study on tunneling nanotubes (TnTs), ... They found that mesothelioma cells contain many ...
(Date:11/22/2014)... A classic black prom dress will never go out of ... unveiled its new items of black prom gowns . ... big discount, up to 70% off. People throughout the world ... prom dresses, made with the best materials, can make wearers ... customers, the company provides these beautiful outfits in a huge ...
Breaking Medicine News(10 mins):Health News:Asher Milgrom Is the Founding Doctor of AMA Skincare and Is Featured in the International Business Times 2Health News:Asher Milgrom Is the Founding Doctor of AMA Skincare and Is Featured in the International Business Times 3Health News:Asher Milgrom Is the Founding Doctor of AMA Skincare and Is Featured in the International Business Times 4Health News:Syngenta Lawsuits Being Investigated by Wright & Schulte LLC, Following China’s Rejection of Corn Shipments Tainted with Unapproved GMO Seed 2Health News:Syngenta Lawsuits Being Investigated by Wright & Schulte LLC, Following China’s Rejection of Corn Shipments Tainted with Unapproved GMO Seed 3Health News:Zane Benefits, Inc. Announces New Webinar on The End of Employer-Provided Health Insurance Now Available On-Demand! 2Health News:Study Links Cellular ‘Tunnels’ to Mesothelioma Proliferation, According to Surviving Mesothelioma 2Health News:New Black Prom Dresses from BellasDress.com 2
... Service (ARS) finds that various forms of peanut flour ... to help food experts to improve food textures. ... oil from roasted peanut seeds. It is added to ... dressings to enhance flavor and protein value. ...
... American client who wants to show it in Tokyo in ... all this from Chennai too! ,But a small company ... Specialising in providing software services to the healthcare sector, it ... in millions of dollars in profit. ,Its ...
... in effectiveness to each other but differ when it ... released today by HHS’ Agency for Healthcare Research and ... of nearly 300 published studies of second-generation antidepressants, show ... relief from the drugs. About six in 10 also ...
... that too much alcohol can lead to multiple health ... of this perception.// Many people also assume that a ... probably alcoholics. This may not be accurate. A recent ... that, in fact, most alcohol-related problems may be due ...
... the bacterium that causes pneumonic plague is significantly slowed when ... Washington University School of// Medicine in St. Louis report in ... a primary concern in pneumonic plague, which kills in three ... terrorist attack. The bacterium that causes plague, Yersinia pestis, is ...
... (MS) is a chronic inflammatory disorder that causes degeneration ... leading to various symptoms including muscle// weakness and pain. ... cycles of disease and remission, leading to the suggestion ... inflammation. Using a mouse model of MS (known as ...
Cached Medicine News:Health News:Cashing in on IT for Healthcare 2Health News:Newer Class of Antidepressants Similar in Effectiveness, Side Effects Differ 2Health News:Newer Class of Antidepressants Similar in Effectiveness, Side Effects Differ 3Health News:Excessive Drinking, Not Alcoholism, may Lead to Most Alcohol-Related Problems 2Health News:Disabling Key Protein may Give Physicians Time to Treat Pneumonic Plague 2
... automated solution for Western Blot analysis ... fully automated Western Blot Analyzer for many ... reveal the presence of infectious diseases such ... fast and accurate screening of allergies and ...
... Advantages of using the Antigen-Antibody Pens-Using a ... and developed specialized fountain pens, called Antigen-Antibody ... or write/mark the blotting membranes in any ... formulated antigen-bonded colored dyes helps to see ...
... the Antigen-Antibody Pens-Using a proprietary and patented ... fountain pens, called Antigen-Antibody pens-TM, that will ... blotting membranes in any form or shape ... dyes helps to see antigen being written ...
... to 350 Liters of pure water, Complete, ... of Purified Water,Millipores compact S.D.S. Storage and ... to 350 liters of purified water produced ... maintain consistent purity of stored water, provide ...
Medicine Products: